EZH2 and leukemia: In leukemias, in which mainly EZH2 loss-of-function occurs, it has recently been shown that EZH2 loss or reduced expression can cause the acquired drug resistance to TKI and cytotoxic drugs in AML as a result of HOX genes de-repression [202].